Pharmaceutical & Medical Devices

Yesterday it was Vioxx. The day before that, it was Fen-Phen. Tomorrow it will be something else. The pharmaceutical industry is a playground for plaintiffs’ lawyers and a breeding ground for MDLs. The medical device industry is comparably exposed, facing lawsuits that make up in severity what they might lack in volume.

It’s not just litigation. There are multiple audiences to assuage, including regulators and global NGOs. There are drug approval processes demanding careful but strategic communications. There are looming controversies on the horizon, from drug shortages to drug costs. There are questions about pharmaceutical marketing practices. And, of course, there are ongoing debates over Medicare and Medicaid that Big Pharma must nimbly and responsibly navigate.

Levick’s Pharmaceutical & Medical Devices team has joined with pharmaceutical and medical companies, big and small, to manage ongoing exposure and current lawsuits, and to begin mapping out communications action plans well ahead of need. The high-stakes issues cover the gamut, from possible melamine contamination in infant formula, to clinical trials seeking a breakthrough treatment for Alzheimer’s disease. 

Crisis management is built into the DNA of pharmaceutical and medical device companies. That means everything is on the table for discussion, and at the earliest possible point in time.